Physician profile
Jeremy J Joyal
NPI 1861622219
$170,061.66
in general payments reported to CMS, 2019-2025
48 companies · $85K in 2025
The $85K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $1,500 · 2021: $2,400 · 2022: $5,376 · 2023: $34K · 2024: $40K · 2025: $85K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $115K · Consulting Fee: $19K · Food and Beverage: $13K · Travel and Lodging: $12K · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $114,750.00 |
| Consulting Fee | $19,408.96 |
| Food and Beverage | $13,059.93 |
| Travel and Lodging | $12,330.10 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $109,896.94 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Therapies |
| Relievant Medsystems, INC. | $34,279.88 | 2020-2023 | Intracept |
| Mml US, INC. | $17,965.47 | 2022-2025 | Reactiv8 |
| Medtronic, INC. | $2,001.22 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $858.09 | 2022-2025 | |
| Medtronic USA, INC. | $650.50 | 2019-2020 | |
| Biotronik Nro, INC. | $603.65 | 2024-2025 | Prospera |
| Saluda Medical Americas, INC. | $385.02 | 2023-2024 | Evoke, Evoke Scs |
| Spr Therapeutics, INC | $383.91 | 2020-2025 | Sprint Pns System |
| Nalu Medical, INC. | $312.07 | 2021-2025 | Nalu Neurostimulation System |
| Merz Pharmaceuticals, LLC | $262.62 | 2023-2025 | Xeomin |
| Zyla Life Sciences, INC. | $213.31 | 2019-2020 | |
| Abbott Laboratories | $212.52 | 2019-2025 | Proclaim |
| Vertos Medical, INC. | $189.85 | 2023-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $178.24 | 2020-2025 | Xtampza, Belbuca |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Joyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.